Age, Sex, and Central Adiposity as Determinants of Autonomic Nervous System Reactivity in Adults
Abstract
1. Introduction
1.1. Anthropometric Measures and Their Health Relevance
1.2. Integrating Psychological, Anthropometric, and Autonomic Perspectives
2. Subjects and Methods
2.1. Study Design and Participants
2.2. Instruments and Measures
2.3. Statistical Analysis
3. Results
3.1. Demographic Data and Measurements
3.2. Hemodynamic Parameters During the LSL Test
3.3. Influence of Demographic and Lifestyle Factors on ANS Reactivity
3.4. Anthropometric Factors and ANS Reactivity
3.5. Effect of Obesity and Central Adiposity
3.6. Relationship Between Psychological and Anthropometric Factors
3.7. Relationship Between Life Stress, Maladaptive Coping Strategies, and Autonomic Regulation
3.8. Sex-Specific Findings
4. Discussion
4.1. Age-Related Differences in Autonomic Reactivity
4.2. Sex Differences in Autonomic Function
4.3. Central Adiposity and Vascular Adaptability
4.4. Maladaptive Coping, Life Stress, and Self-Reported Quality of Life
4.5. Integration and Implications
4.6. Strengths and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Chu, B.; Marwaha, K.; Sanvictores, T.; Awosika, A.; Ayers, D. Physiology, Stress Reaction. [Updated 2024 May 7]. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2024. Available online: https://www.ncbi.nlm.nih.gov/books/NBK541120/ (accessed on 10 August 2025).
- Kumar, R.; Rizvi, M.R.; Saraswat, S. Obesity and Stress: A Contingent Paralysis. Int. J. Prev. Med. 2022, 13, 95. [Google Scholar] [CrossRef] [PubMed]
- Parati, G.; Schumacher, H. Blood pressure variability over 24 h: Prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination. Hypertens. Res. 2014, 37, 187–193. [Google Scholar] [CrossRef] [PubMed]
- Laurent, S.; Cockcroft, J.; Van Bortel, L.; Boutouyrie, P.; Giannattasio, C.; Hayoz, D.; Pannier, B.; Vlachopoulos, C.; Wilkinson, I.; Struijker-Boudier, H.; et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur. Heart J. 2006, 27, 2588–2605. [Google Scholar] [CrossRef]
- Vlachopoulos, C.; Aznaouridis, K.; Stefanadis, C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 55, 1318–1327. [Google Scholar] [CrossRef]
- Schoenmakers, E.C.; van Tilburg, T.G.; Fokkema, T. Problem-focused and emotion-focused coping options and loneliness: How are they related? Eur. J. Ageing 2015, 12, 153–161. [Google Scholar] [CrossRef]
- Young, J.E.; Klosko, J.S.; Weishaar, M.E. Schema Therapy: A Practitioner’s Guide; Guilford Press: New York, NY, USA, 2003; p. 436. [Google Scholar]
- Cholankeril, R.; Xiang, E.; Badr, H. Gender Differences in Coping and Psychological Adaptation during the COVID-19 Pandemic. Int. J. Environ. Res. Public Health 2023, 20, 993. [Google Scholar] [CrossRef]
- Costa, C.; Briguglio, G.; Mondello, S.; Teodoro, M.; Pollicino, M.; Canalella, A.; Verduci, F.; Italia, S.; Fenga, C. Perceived Stress in a Gender Perspective: A Survey in a Population of Unemployed Subjects of Southern Italy. Front. Public Health 2021, 9, 640454. [Google Scholar] [CrossRef]
- Russell, S.L.; Rahman, M.; Steward, C.J.; Harwood, A.E.; McGregor, G.; Banerjee, P.; Okwose, N.C.; Jakovljevic, D.G. Central Pulse Wave Velocity and Augmentation Index Are Repeatable and Reproducible Measures of Arterial Function. Health Sci. Rep. 2024, 7, e70155. [Google Scholar] [CrossRef]
- Holmes, T.H.; Rahe, R.H. The Social Readjustment Rating Scale. J. Psychosom. Res. 1967, 11, 213–218. [Google Scholar] [CrossRef] [PubMed]
- Nieuwenhuis, S.; Forstmann, B.U.; Wagenmakers, E.J. Erroneous analyses of interactions in neuroscience: A problem of significance. Nat. Neurosci. 2011, 14, 1105–1107. [Google Scholar] [CrossRef]
- Laurent, S.; Boutouyrie, P. Arterial stiffness: A new surrogate end point for cardiovascular disease? J. Nephrol. 2007, 20 (Suppl. 12), S45–S50. [Google Scholar] [PubMed]
- Parati, G.; Esler, M. The human sympathetic nervous system: Its relevance in hypertension and heart failure. Eur. Heart J. 2012, 33, 1058–1066. [Google Scholar] [CrossRef]
- Monahan, K.D. Effect of aging on baroreflex function in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293, R3–R12. [Google Scholar] [CrossRef]
- Safar, M.E.; London, G.M. Arterial and venous compliance in sustained essential hypertension. Hypertension 1987, 10, 133–139. [Google Scholar] [CrossRef]
- Cecelja, M.; Chowienczyk, P. Role of arterial stiffness in cardiovascular disease. JRSM Cardiovasc. Dis. 2012, 1, 1–10. [Google Scholar] [CrossRef]
- DuPont, J.J.; Kenney, R.M.; Patel, A.R.; Jaffe, I.Z. Sex differences in mechanisms of arterial stiffness. Br. J. Pharmacol. 2019, 176, 4208–4225. [Google Scholar] [CrossRef]
- Barnes, J.N. Sex-specific factors regulating pressure and flow. Exp. Physiol. 2017, 102, 1385–1392. [Google Scholar] [CrossRef]
- Hay, M. Sex, the brain and hypertension: Brain oestrogen receptors and high blood pressure risk factors. Clin. Sci. 2016, 130, 9–18. [Google Scholar] [CrossRef] [PubMed]
- Czernichow, S.; Kengne, A.P.; Stamatakis, E.; Hamer, M.; Batty, G.D. Body mass index, waist circumference and waist-hip ratio: Which is the better discriminator of cardiovascular disease mortality risk? Evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes. Rev. 2011, 12, 680–687. [Google Scholar] [CrossRef] [PubMed]
- Lear, S.A.; Humphries, K.H.; Kohli, S.; Birmingham, C.L. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity 2007, 15, 2817–2824. [Google Scholar] [CrossRef]
- Emamat, H.; Jamshidi, A.; Farhadi, A.; Ghalandari, H.; Ghasemi, M.; Tangestani, H. The association between the visceral to subcutaneous abdominal fat ratio and the risk of cardiovascular diseases: A systematic review. BMC Public Health 2024, 24, 1827. [Google Scholar] [CrossRef]
- Rocha, V.Z.; Libby, P. Obesity, inflammation, and atherosclerosis. Nat. Rev. Cardiol. 2009, 6, 399–409. [Google Scholar] [CrossRef] [PubMed]
- Tentolouris, N.; Liatis, S.; Katsilambros, N. Sympathetic system activity in obesity and metabolic syndrome. Ann. N. Y. Acad. Sci. 2006, 1083, 129–152. [Google Scholar] [CrossRef] [PubMed]
- Manolopoulos, K.N.; Karpe, F.; Frayn, K.N. Gluteofemoral body fat as a determinant of metabolic health. Int. J. Obes. 2010, 34, 949–959. [Google Scholar] [CrossRef]
- Tyra, A.T.; Fergus, T.A.; Ginty, A.T. Emotion suppression and acute physiological responses to stress in healthy populations: A quantitative review of experimental and correlational investigations. Health Psychol. Rev. 2024, 18, 396–420. [Google Scholar] [CrossRef]
- Kim, H.G.; Cheon, E.J.; Bai, D.S.; Lee, Y.H.; Koo, B.H. Stress and Heart Rate Variability: A Meta-Analysis and Review of the Literature. Psychiatry Investig. 2018, 15, 235–245. [Google Scholar] [CrossRef]
- Cattaneo, L.A.; Franquillo, A.C.; Grecucci, A.; Beccia, L.; Caretti, V.; Dadomo, H. Is Low Heart Rate Variability Associated with Emotional Dysregulation, Psychopathological Dimensions, and Prefrontal Dysfunctions? An Integrative View. J. Pers. Med. 2021, 11, 872. [Google Scholar] [CrossRef]
- Sinha, R.; Jastreboff, A.M. Stress as a common risk factor for obesity and addiction. Biol. Psychiatry 2013, 73, 827–835. [Google Scholar] [CrossRef]
- Kivimaki, M.; Steptoe, A. Effects of stress on the development and progression of cardiovascular disease. Nat. Rev. Cardiol. 2018, 15, 215–229. [Google Scholar] [CrossRef] [PubMed]
- Kershaw, K.N.; Brenes, G.A.; Charles, L.E.; Coday, M.; Daviglus, M.L.; Denburg, N.L.; Kroenke, C.H.; Safford, M.M.; Savla, T.; Tindle, H.A.; et al. Associations of stressful life events and social strain with incident cardiovascular disease in the Women’s Health Initiative. J. Am. Heart Assoc. 2014, 3, e000687. [Google Scholar] [CrossRef]
- De Smedt, D.; Clays, E.; Annemans, L.; Pardaens, S.; Kotseva, K.; De Bacquer, D. Self-reported health status in coronary heart disease patients: A comparison with the general population. Eur. J. Cardiovasc. Nurs. 2015, 14, 117–125. [Google Scholar] [CrossRef] [PubMed]
- Pinheiro, L.C.; Reshetnyak, E.; Sterling, M.R.; Richman, J.S.; Kern, L.M.; Safford, M.M. Using health-related quality of life to predict cardiovascular disease events. Qual. Life Res. 2019, 28, 1465–1475. [Google Scholar] [CrossRef]
- Janssen, M.F.; Pickard, A.S.; Golicki, D.; Gudex, C.; Niewada, M.; Scalone, L.; Swinburn, P.; Busschbach, J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Qual. Life Res. 2013, 22, 1717–1727. [Google Scholar] [CrossRef]
- Mikkelsen, M.B.; O’Toole, M.S.; Elkjaer, E.; Mehlsen, M. The effect of age on emotion regulation patterns in daily life: Findings from an experience sampling study. Scand. J. Psychol. 2024, 65, 231–239. [Google Scholar] [CrossRef]
- Isaacowitz, D.M. What Do We Know About Aging and Emotion Regulation? Perspect. Psychol. Sci. 2022, 17, 1541–1555. [Google Scholar] [CrossRef] [PubMed]
- Charles, S.T.; Piazza, J.R.; Luong, G.; Almeida, D.M. Now you see it, now you don’t: Age differences in affective reactivity to social tensions. Psychol. Aging 2009, 24, 645–653. [Google Scholar] [CrossRef] [PubMed]
Subjects | Total | Males | Females | p |
---|---|---|---|---|
(N,%) | 122 | 40 (32.79%) | 82 (67.21%) | <0.001 |
Variable | Mean ± SD/n (%) | |||
Demographic and Lifestyle | ||||
Age (years) | 40.5 (27–78) | 43.50 (21–78) | 40 (21–70) | 0.71 |
In Partnership (N,%) | 80/122 (65.57%) | 54/82 (65.85%) | 26/40 (65.00%) | 0.75 |
Smoking (yes; N,%) | 27/122 (22.13%) | 19/82 (23.17%) | 8/40 (20.00%) | 0.87 |
Physical Activity (hours per week) | 4.0 (0.0–46.0) | 4.0 (0.0–46.0) | 3.0 (0–45.0) | 0.21 |
Anthropometric Measurements | ||||
Height (cm) | 170.0 (156.0–196.0) | 180.00 (169.00–195.00) | 168.00 (156.00–180.00) | <0.001 |
Weight (kg) | 67.36 (43.3–130.77) | 85.06 (53.47–130.77) | 62.89 (43.30–109.53) | <0.001 |
Waist Circumference (cm) | 80.0 (59.0–130.0) | 96.00 (76.00–130.00) | 73.00 (59.00–111.00) | <0.001 |
Hip Circumference (cm) | 99.0 (80.0–136.0) | 103.00 (89.00–120.00) | 96.00 (80.00–136.00) | <0.001 |
BMI (kg/m2) | 23.35 (16.5–41.3) | 26.30 (18.50–41.30) | 22.20 (16.50–37.90) | <0.001 |
WHtR | 0.47 (0.36–0.69) | 0.52 (0.44–0.69) | 0.44 (0.36–0.67) | <0.001 |
WHR | 0.87 (0.71–1.23) | 0.91 (0.78–1.07) | 0.85 (0.71–1.23) | <0.001 |
Psychological and Coping Measures | ||||
EQ-5D-3L | 80 (30–100) | 80 (30–100) | 80.00 (40.00–100.00) | 0.35 |
LEI (LCU) | 108.5 (0–633.0) | 102.00 (0.00–332.00) | 109.00 (0.00–633.00) | 0.77 |
YCI Total Score | 140.5 (3.04–212.0) | 146.00 (48.00–212.00) | 139.00 (69.00–190.00) | 0.53 |
YCI Average Score | 2.93 (1.0–4.42) | 3.04 (1.00–4.42) | 2.90 (1.44–3.96) | 0.41 |
YCI Social Control | 2.71 (1.0–4.26) | 2.84 (1.00–4.26) | 2.63 (1.26–4.05) | 0.30 |
YCI Individuality | 3.30 (1.0–4.9) | 3.40 (1.00–4.60) | 3.20 (1.70–4.90) | 0.26 |
YCI Personal Control | 3.50 (1.0–5.5) | 3.25 (1.00–5.50) | 3.50 (1.00–5.50) | 0.24 |
Hemodynamic parameters | ||||
Systolic BP (mmHg) | 123.5 (91.00–156.50) | 132.50 (105.00–156.50) | 118.50 (91.00–149.50) | <0.001 |
Diastolic BP (mmHg) | 70.00 (48.50–94.50) | 75.50 (56.00–94.50) | 67.75 (48.50–149.50) | <0.001 |
HR (bpm) | 71 (45.00–103.00) | 70.00 (45.00–88.00) | 71.50 (54.00–103.00) | 0.29 |
Parameter | Phase | Total | Males | Females | p | HL (M-F) |
---|---|---|---|---|---|---|
HR (bpm) | L1 | 64.9 (38.78–94.19) | 63.85 (38.78–92.04) | 65.80 (45.57–94.19) | 0.31 | −2.16 |
S | 79.96 (47.19–114.05) | 80.47 (47.19–108.17) | 79.79 (55.27–114.05) | 0.67 | −0.95 | |
L2 | 64.16 (39.57–91.73) | 64.16 (39.57–90.11) | 64.44 (46.86–91.73) | 0.36 | −1.76 | |
ΔHR (bpm) | L1-S | 15.79 (1.05–41.13) | 15.81 (8.09–41.13) | 15.79 (1.05–35.70) | 0.88 | 0.17 |
S-L2 | −17.01 (−39.44–−2.36) | −16.47 (−39.44–−6.63) | −17.23 (−38.10–−2.36) | 0.94 | −0.04 | |
L1-L2 | −0.86 (−11.65–6.54) | −0.73 (−8.37–6.54) | −0.99 (−11.65–4.11) | 0.66 | 0.20 | |
RR (brpm) | L1 | 15.54 (6.48–18.92) | 15.85 (8.30–18.65) | 15.36 (6.48–18.92) | 0.21 | 0.59 |
S | 14.67 (6.83–18.88) | 14.64 (10.30–18.88) | 14.68 (6.83–18.65) | 0.55 | 0.26 | |
L2 | 15.69 (6.76–19.38) | 15.91 (7.06–18.72) | 15.63 (6.76–19.38) | 0.10 | 0.00 | |
ΔRR (brpm) | L1-S | −0.28 (−4.98–3.37) | −0.79 (−4.98–2.97) | −0.07 (−4.95–3.37) | 0.66 | −0.15 |
S-L2 | 0.41 (−4.21–5.68) | 0.25 (−4.21–4.32) | 0.45 (−3.12–5.68) | 0.21 | −0.48 | |
L1-L2 | 0.22 (−4.15–3.58) | 0.01 (−4315–2.16) | 0.35 (−2.97–3.58) | 0.003 | −0.54 | |
AIxA (%) | L1 | 25.0 (1.05–61.5) | 19.50 (1.05–48.65) | 27.83 (3.45–61.50) | 0.02 | −6.60 |
S | 16.28 (−3.1–54.95) | 13.83 (−3.10–40.05) | 21.05 (−0.30–54.95) | 0.01 | −6.50 | |
L2 | 27.55 (3.2–62.7) | 22.03 (3.20–52.20) | 29.45 (5.50–62.70) | 0.01 | −7.30 | |
ΔAIxA (%) | L1-S | −6.3 (−33.5–17.45) | −6.10 (−31.20–17.45) | −6.63 (−33.5–11.20) | 0.76 | −0.65 |
S-L2 | 8.35 (−16.75–38.7) | 9.25 (−16.75–32.90) | 8.08 (−8.80–38.70) | 0.82 | 0.30 | |
L1-L2 | 2.05 (−8.3–15.2) | 1.40 (−8.30–9.20) | 2.33 (−5.58–15.20) | 0.50 | −0.40 | |
AIxB (%) | L1 | −24.93 (−72.35–47.15) | −35.90 (−72.35–21.80) | −19.35 (−67.50–47.15) | 0.02 | −13.00 |
S | −42.25 (−80.5–34.2) | −47.08 (−80.50–4.70) | −33.25 (−74.90–34.20) | 0.01 | −12.50 | |
L2 | −19.55 (−68.05–49.55) | −27.75 (−68.05–28.75) | −16.20 (−63.45–49.55) | 0.02 | −12.50 | |
ΔAIxB (%) | L1-S | −12.4 (−66.15–34.5) | −12.00 (−31.50–34.50) | −13.13 (−66.15–20.10) | 0.76 | −1.55 |
S-L2 | 17.08 (−33.1–76.45) | 20.00 (−33.10–75.00) | 15.95 (−17.35–76.45) | 0.56 | 1.90 | |
L1-L2 | 4.03 (−16.4–76.75) | 3.48 (−16.40–76.75) | 4.48 (−9.85–30.05) | 0.69 | −0.53 | |
SBPao (mmHg) | L1 | 122.18 (92.6–180.1) | 124.15 (95.85–165.35) | 119.40 (92.60–180.10) | 0.44 | 2.50 |
S | 123.93 (101.8–187.8) | 122.90 (102.15–187.80) | 125.23 (101.80–158.70) | 0.72 | −1.10 | |
L2 | 121.90 (−2.0–170.15) | 124.83 (−2.00–164.35) | 121.48 (90.35–170.15) | 0.66 | 2.15 | |
ΔSBPao (mmHg) | L1-S | 4.30 (−37.55–36.45) | 4.00 (−32.15–36.45) | 4.58 (−37.55–20.40) | 0.44 | −1.10 |
S-L2 | −3.35 (−117.87–34.75) | −3.40 (−117.85–34.75) | −3.15 (−20.50–27.60) | 0.96 | 0.48 | |
L1-L2 | 0.85 (−119.5–17.95) | 1.35 (−119.50–11.15) | 0.50 (−11.80–17.95) | 0.83 | 0.00 | |
PPao (mmHg) | L1 | 44.78 (30.0–87.95) | 43.75 (30.00–67.45) | 46.28 (32.60–87.95) | 0.28 | −1.80 |
S | 39.93 (28.25–73.2) | 40.68 (28.60–55.55) | 39.78 (28.25–73.20) | 0.48 | −1.10 | |
L2 | 45.58 (−12.0–87.85) | 45.05 (−12.00–69.25) | 45.63 (32.50–87.85) | 0.23 | −1.55 | |
ΔPPao (mmHg) | L1-S | −4.78 (−36.5–10.75) | −4.90 (−25.45–7.85) | −4.53 (−36.50–10.75) | 1.00 | 0.00 |
S-L2 | 5.38 (−49.85–27.1) | 4.80 (−49.85–21.90) | 5.80 (−10.70–27.10) | 0.76 | −0.15 | |
L1-L2 | 1.15 (−42.0–13.95) | 1.33 (−42.00–10.15) | 0.95 (−14.80–13.95) | 0.79 | −0.05 | |
PWVao (m/s) | L1 | 8.25 (5.75–14.40) | 8.10 (5.80–12.60) | 8.30 (5.75–14.40) | 0.29 | 0.35 |
S | 9.20 (6.90–14.45) | 10.15 (7.20–14.45) | 9.00 (6.90–13.40) | 0.002 | 1.05 | |
L2 | 8.28 (4.40–15.25) | 8.43 (5.20–13.15) | 8.18 (4.40–15.25) | 0.33 | 0.25 | |
ΔPWVao (m/s) | L1-S | 1.15 (−5.40–8.65) | 1.60 (−5.40–8.65) | 0.90 (−3.95–5.25) | 0.01 | 0.70 |
S-L2 | −1.08 (−8.60–2.50) | −1.53 (−8.60–0.80) | −0.63 (−5.15–2.50) | 0.01 | −0.70 | |
L1-L2 | 0.08 (−7.40–3.15) | 0.13 (−7.40–2.10) | 0.05 (−3.90–3.15) | 0.42 | 0.10 |
YCI-SC | YCI-I | YCI-PC | YCI-AVG | LEI | EQ-5D-3L | |
---|---|---|---|---|---|---|
Age | −0.25 * | −0.32 ** | −0.18 | −0.29 * | −0.07 | −0.03 |
Weight | 0.13 | 0.02 | 0.05 | 0.14 | 0.04 | −0.08 |
Height | 0.02 | 0.11 | −0.13 | 0.05 | −0.07 | 0.07 |
BMI | 0.10 | −0.04 | 0.07 | 0.08 | 0.07 | −0.11 |
Waist circumference | 0.08 | −0.03 | 0.08 | 0.05 | 0.06 | −0.12 |
Hip circumference | 0.03 | −0.05 | 0.07 | 0.03 | 0.01 | −0.08 |
WHR | 0.02 | −0.14 | 0.04 | −0.03 | 0.00 | −0.12 |
WHtR | 0.09 | −0.06 | 0.11 | 0.04 | 0.06 | −0.14 |
Females | ||||||
Age | −0.32 * | −0.28 | −0.19 | −0.35 * | −0.08 | −0.05 |
Weight | 0.10 | −0.04 | 0.12 | 0.10 | 0.15 | −0.10 |
Height | −0.14 | 0.04 | −0.25 | −0.08 | −0.05 | 0.10 |
BMI | 0.11 | −0.04 | 0.15 | 0.10 | 0.18 | −0.10 |
Waist circumference | 0.04 | −0.11 | 0.17 | 0.03 | 0.18 | −0.13 |
Hip circumference | −0.04 | −0.11 | 0.09 | −0.02 | 0.07 | −0.05 |
WHR | 0.04 | −0.19 | 0.14 | 0.01 | 0.14 | −0.17 |
WHtR | 0.08 | −0.08 | 0.21 | 0.06 | 0.18 | −0.15 |
Males | ||||||
Age | −0.14 | −0.36 * | −0.17 | −0.19 | 0.00 | 0.01 |
Weight | −0.01 | 0.04 | 0.09 | 0.10 | −0.25 | −0.09 |
Height | 0.18 | 0.17 | 0.31 | 0.22 | −0.13 | 0.01 |
BMI | −0.10 | −0.08 | −0.03 | −0.04 | −0.22 | −0.10 |
Waist circumference | −0.04 | −0.05 | 0.08 | −0.01 | −0.24 | −0.14 |
Hip circumference | 0.04 | 0.02 | 0.11 | 0.07 | −0.29 | −0.03 |
WHR | −0.17 | −0.14 | −0.11 | −0.19 | −0.32 | 0.01 |
WHtR | −0.07 | −0.14 | −0.01 | −0.07 | −0.24 | −0.11 |
Outcome | Predictor | F β_std [95% CI] | q_F | R2_F | n_F | M β_std [95% CI] | q_M | R2_M | n_M | q_Interaction |
---|---|---|---|---|---|---|---|---|---|---|
YCI-AVG | Age | −0.43 [−0.69, −0.16] | 0.011 | 0.217 | 80 | - | 0.499 | |||
YCI-SC | Age | −0.41 [−0.68, −0.13] | 0.021 | 0.18 | 80 | - | 0.523 | |||
YCI-PC | Age | −0.42 [−0.67, −0.16] | 0.009 | 0.263 | 80 | - | 0.918 | |||
YCI-PC | Waist (cm) | 0.70 [0.24, 1.17] | 0.009 | 0.263 | 80 | - | 0.607 | |||
YCI-PC | Hips (cm) | −0.61 [−1.05, −0.17] | 0.012 | 0.263 | 80 | - | 0.918 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Majerčák, I.; Jochmanová, I.; Šlepecký, M.; Kotianová, A.; Kotian, M.; Praško, J.; Zaťková, M. Age, Sex, and Central Adiposity as Determinants of Autonomic Nervous System Reactivity in Adults. Medicina 2025, 61, 1682. https://doi.org/10.3390/medicina61091682
Majerčák I, Jochmanová I, Šlepecký M, Kotianová A, Kotian M, Praško J, Zaťková M. Age, Sex, and Central Adiposity as Determinants of Autonomic Nervous System Reactivity in Adults. Medicina. 2025; 61(9):1682. https://doi.org/10.3390/medicina61091682
Chicago/Turabian StyleMajerčák, Ivan, Ivana Jochmanová, Miloš Šlepecký, Antónia Kotianová, Michal Kotian, Ján Praško, and Marta Zaťková. 2025. "Age, Sex, and Central Adiposity as Determinants of Autonomic Nervous System Reactivity in Adults" Medicina 61, no. 9: 1682. https://doi.org/10.3390/medicina61091682
APA StyleMajerčák, I., Jochmanová, I., Šlepecký, M., Kotianová, A., Kotian, M., Praško, J., & Zaťková, M. (2025). Age, Sex, and Central Adiposity as Determinants of Autonomic Nervous System Reactivity in Adults. Medicina, 61(9), 1682. https://doi.org/10.3390/medicina61091682